An analysis of data from the Young Women’s Breast Cancer Study, involving 1,071 individuals diagnosed with breast cancer before the age of 40, revealed significant delays in care among this population. The study identified 153 presentation delays, 120 diagnostic delays, and 228 treatment delays, defined as ≥90 days, ≥90 days, and ≥60 days respectively, from symptom onset to clinical presentation, diagnosis, and first treatment. Lower annual income was associated with a higher likelihood of presentation delay.
Conversely, pregnancy at diagnosis, family history of breast cancer, and triple-negative breast cancer were linked to reduced presentation delays. Presentation delays were also associated with later stage disease in women with certain HER2-positive tumors. Diagnostic delays were more common in younger patients and less common in those with triple-negative tumors. Those who experienced a delay in breast cancer diagnosis were more likely to have late-stage disease. Treatment delays were less likely for patients with more aggressive tumor types. The study did not find an association between delays and cancer-free survival or overall survival. The authors noted that later stage diagnoses may necessitate more extensive treatments, potentially impacting quality of life and other outcomes. The research highlights ongoing issues with care delays in young-onset breast cancer and emphasizes the need for improved patient and provider understanding of risk factors and symptoms to reduce the disease burden in this group.